Home
>
National Drug Code (NDC)
>
BACiiM
BACiiM - 39822-0277-5 - (Bacitracin)
Drug Information of BACiiM
| Product NDC: | 39822-0277 |
| Proprietary Name: | BACiiM |
| Non Proprietary Name: | Bacitracin |
| Active Ingredient(s): | 50000 [USP'U]/1 & nbsp; Bacitracin |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BACiiM
| Product NDC: | 39822-0277 |
| Labeler Name: | X-GEN Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA064153 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970509 |
Package Information of BACiiM
| Package NDC: | 39822-0277-5 |
| Package Description: | 10 VIAL in 1 CARTON (39822-0277-5) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (39822-0277-2) |
NDC Information of BACiiM
| NDC Code | 39822-0277-5 |
| Proprietary Name | BACiiM |
| Package Description | 10 VIAL in 1 CARTON (39822-0277-5) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (39822-0277-2) |
| Product NDC | 39822-0277 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bacitracin |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19970509 |
| Marketing Category Name | ANDA |
| Labeler Name | X-GEN Pharmaceuticals, Inc. |
| Substance Name | BACITRACIN |
| Strength Number | 50000 |
| Strength Unit | [USP'U]/1 |
| Pharmaceutical Classes | Decreased Cell Wall Synthesis & Repair [PE] |
